Sio Capital Management, LLC
AdviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 98.6%; sector active share 84.3% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
59 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 93.6% | $565,842,053 |
| Industrials | 6.4% | $38,452,753 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SENS | Senseonics Holdings, Inc. | +1,476,908 | 1,592,692 | $9,046,490 | |
| AVR | Anteris Technologies Global Corp. | +163,019 | 5,545,984 | $54,627,942 | |
| SNY | Sanofi | +124,529 | 364,200 | $15,536,772 | |
| TYRA | Tyra Biosciences, Inc. | +89,876 | 695,315 | $22,208,361 | |
| COR | Cencora, Inc. | +72,694 | 173,588 | $49,121,932 | |
| ZBH | Zimmer Biomet Holdings, Inc. | +68,832 | 131,445 | $11,316,100 | |
| GSK | GSK plc | +50,821 | 436,700 | $22,891,814 | |
| ORKA | Oruka Therapeutics, Inc. | +44,622 | 177,118 | $16,856,320 | |
| RLMD | Relmada Therapeutics, Inc. | +38,562 | 1,003,562 | $6,944,649 | |
| SVRA | Savara Inc | +3,787 | 617,675 | $3,804,878 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| WAY | Waystar Holding Corp. | −716,402 | 925,834 | $19,007,372 | |
| ADGM | Adagio Medical Holdings, Inc. | −589,472 | 698,989 | $455,740 | |
| PMVP | PMV Pharmaceuticals, Inc. | −442,443 | 2,634,137 | $3,529,743 | |
| AQST | Aquestive Therapeutics, Inc. | −436,712 | 1,486,175 | $6,182,488 | |
| OCUL | Ocular Therapeutix, Inc | −429,104 | 539,493 | $5,297,821 | |
| VIR | Vir Biotechnology, Inc. | −423,346 | 1,075,274 | $10,957,042 | |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | −413,847 | 82,767 | $251,611 | |
| DNTH | Dianthus Therapeutics, Inc. | −310,791 | 59,254 | $5,776,079 | |
| OVID | Ovid Therapeutics Inc. | −247,047 | 1,005,334 | $2,704,348 | |
| ICLR | Icon PLC | −218,172 | 88,186 | $15,318,790 | |
| ANIP | Ani Pharmaceuticals Inc | −168,238 | 97,305 | $8,054,907 | |
| SION | Sionna Therapeutics, Inc. | −166,532 | 127,808 | $5,622,273 | |
| ANTX | AN2 Therapeutics, Inc. | −127,267 | 529,933 | $2,564,875 | |
| ZBIO | Zenas BioPharma, Inc. | −123,173 | 208,557 | $5,293,176 | |
| EYPT | EyePoint, Inc. | −98,655 | 623,130 | $8,910,759 | |
| CELC | Celcuity Inc. | −83,821 | 110,022 | $11,510,501 | |
| RAPP | Rapport Therapeutics, Inc. | −59,152 | 307,657 | $12,820,067 | |
| ABT | Abbott Laboratories | −57,918 | 128,656 | $11,674,245 | |
| MMS | Maximus, Inc. | −53,558 | 715,267 | $38,452,753 | |
| TARA | Protara Therapeutics, Inc. | −47,967 | 1,921,872 | $7,341,551 | |
| IMNM | Immunome Inc. | −40,942 | 124,168 | $2,631,119 | |
| DRUG | Bright Minds Biosciences Inc. | −12,131 | 73,952 | $5,191,430 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | 13,323,431 | $27,712,736 | |
| GMED | Globus Medical Inc | 301,816 | $23,846,482 | |
| IDYA | IDEAYA Biosciences, Inc. | 480,383 | $17,903,874 | |
| CI | Cigna Group | 57,750 | $15,920,520 | |
| VTRS | Viatris Inc | 954,299 | $15,154,268 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 18,000 | $11,223,720 | |
| BMY | Bristol Myers Squibb Co | 193,500 | $11,149,470 | |
| MDT | Medtronic plc | 142,500 | $11,147,775 | |
| HELP | Helus Pharma Inc. | 1,300,000 | $8,593,000 | |
| TNGX | Tango Therapeutics, Inc. | 208,500 | $6,517,710 | |
| AVAH | Aveanna Healthcare Holdings, Inc. | 369,036 | $3,162,638 | |
| AORT | Artivion, Inc. | 48,481 | $1,089,368 | |
| ENVB | Enveric Biosciences, Inc. | 180,000 | $248,400 | |
| QTI | Qt Imaging Holdings, Inc. | 15,236 | $62,010 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 674,759 | $27,199,535 | |
| LIVN | LivaNova PLC | 421,615 | $26,797,849 | |
| EMBC | Embecta Corp. | 1,847,850 | $16,334,994 | |
| ABVX | Abivax S.A. | 135,800 | $15,121,330 | |
| HAE | Haemonetics Corp | 220,672 | $12,437,073 | |
| TFX | Teleflex Inc | 94,800 | $11,339,028 | |
| BMRN | Biomarin Pharmaceutical Inc | 194,226 | $10,971,826 | |
| GPCR | Structure Therapeutics Inc. | 209,093 | $10,078,282 | |
| BHVN | Biohaven Ltd. | 1,163,926 | $9,846,813 | |
| MNPR | Monopar Therapeutics | 173,506 | $9,506,393 | |
| — | 249,887 | $9,075,895 | ||
| EWTX | Edgewise Therapeutics, Inc. | 268,986 | $8,473,059 | |
| CMPS | COMPASS Pathways plc | 1,506,525 | $8,331,083 | |
| QDEL | QuidelOrtho Corp | 359,011 | $5,898,550 | |
| REPL | Replimune Group, Inc. | 720,036 | $5,508,275 | |
| OGN | Organon & Co. | 865,908 | $5,186,788 | |
| IRON | Disc Medicine, Inc. | 65,203 | $4,169,079 | |
| IART | Integra Lifesciences Holdings Corp | 383,140 | $3,609,178 | |
| PRQR | ProQR Therapeutics N.V. | 1,954,715 | $3,166,638 | |
| SI | Shoulder Innovations, Inc. | 210,641 | $3,060,613 | |
| KYMR | Kymera Therapeutics, Inc. | 32,235 | $2,684,853 | |
| CNTX | Context Therapeutics Inc. | 917,922 | $2,404,955 | |
| HYPR | Hyperfine, Inc. | 1,000,000 | $1,080,000 | |
| FHTX | Foghorn Therapeutics Inc. | 122,889 | $587,409 | |
| — | 10,100 | $532,472 | ||
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Added | 5,545,984 | $54,627,942 | 9.04% | |
| COR |
Cencora, Inc.
Healthcare
|
Added | 173,588 | $49,121,932 | 8.13% | |
| MMS |
Maximus, Inc.
Industrials
|
Reduced | 715,267 | $38,452,753 | 6.36% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
NEW | 13,323,431 | $27,712,736 | 4.59% | |
| GMED |
Globus Medical Inc
Healthcare
|
NEW | 301,816 | $23,846,482 | 3.95% | |
| GSK |
GSK plc
Healthcare
|
Added | 436,700 | $22,891,814 | 3.79% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 695,315 | $22,208,361 | 3.68% | |
| WAY |
Waystar Holding Corp.
Healthcare
|
Reduced | 925,834 | $19,007,372 | 3.15% | |
| SLS |
SELLAS Life Sciences Group, Inc.
PUT
Healthcare
|
NEW | 1,230,700 | $18,165,132 | 3.01% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
NEW | 480,383 | $17,903,874 | 2.96% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Added | 177,118 | $16,856,320 | 2.79% | |
| CI |
Cigna Group
Healthcare
|
NEW | 57,750 | $15,920,520 | 2.63% | |
| SNY |
Sanofi
Healthcare
|
Added | 364,200 | $15,536,772 | 2.57% | |
| ICLR |
Icon PLC
Healthcare
|
Reduced | 88,186 | $15,318,790 | 2.53% | |
| VTRS |
Viatris Inc
Healthcare
|
NEW | 954,299 | $15,154,268 | 2.51% | |
|
|
Held | 1,098,393 | $14,509,772 | 2.40% | ||
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Reduced | 307,657 | $12,820,067 | 2.12% | |
| ABT |
Abbott Laboratories
Healthcare
|
Reduced | 128,656 | $11,674,245 | 1.93% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 110,022 | $11,510,501 | 1.90% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Added | 131,445 | $11,316,100 | 1.87% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
NEW | 18,000 | $11,223,720 | 1.86% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
NEW | 193,500 | $11,149,470 | 1.85% | |
| MDT |
Medtronic plc
Healthcare
|
NEW | 142,500 | $11,147,775 | 1.84% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
Reduced | 1,075,274 | $10,957,042 | 1.81% | |
| SENS |
Senseonics Holdings, Inc.
Healthcare
|
Added | 1,592,692 | $9,046,490 | 1.50% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Reduced | 623,130 | $8,910,759 | 1.47% | |
| HELP |
Helus Pharma Inc.
Healthcare
|
NEW | 1,300,000 | $8,593,000 | 1.42% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Reduced | 97,305 | $8,054,907 | 1.33% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
Reduced | 1,921,872 | $7,341,551 | 1.21% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
Added | 1,003,562 | $6,944,649 | 1.15% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 208,500 | $6,517,710 | 1.08% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Reduced | 1,486,175 | $6,182,488 | 1.02% | |
| DNTH |
Dianthus Therapeutics, Inc.
Healthcare
|
Reduced | 59,254 | $5,776,079 | 0.96% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Reduced | 127,808 | $5,622,273 | 0.93% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Reduced | 539,493 | $5,297,821 | 0.88% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Reduced | 208,557 | $5,293,176 | 0.88% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Reduced | 73,952 | $5,191,430 | 0.86% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Held | 1,078,965 | $4,920,080 | 0.81% | |
| SVRA |
Savara Inc
Healthcare
|
Added | 617,675 | $3,804,878 | 0.63% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,634,137 | $3,529,743 | 0.58% | |
| AVAH |
Aveanna Healthcare Holdings, Inc.
Healthcare
|
NEW | 369,036 | $3,162,638 | 0.52% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Reduced | 1,005,334 | $2,704,348 | 0.45% | |
| IMNM |
Immunome Inc.
Healthcare
|
Reduced | 124,168 | $2,631,119 | 0.44% | |
| HIMS |
Hims & Hers Health, Inc.
CALL
Healthcare
|
NEW | 75,000 | $2,600,250 | 0.43% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
Reduced | 529,933 | $2,564,875 | 0.42% | |
| SER |
Serina Therapeutics, Inc.
Healthcare
|
Held | 1,000,000 | $1,940,000 | 0.32% | |
| ALGS |
Aligos Therapeutics, Inc.
Healthcare
|
Held | 327,237 | $1,888,157 | 0.31% | |
| IBIO |
iBio, Inc.
Healthcare
|
Held | 904,268 | $1,582,469 | 0.26% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
Held | 152,464 | $1,460,605 | 0.24% | |
| AORT |
Artivion, Inc.
Healthcare
|
NEW | 48,481 | $1,089,368 | 0.18% |
Showing the top 50 of 59 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.